Gastroenterologist | Medical Director, Oshi Health | LinkedIn Top Healthcare Management Voice | Forbes Health Contributor

I’m a board-certified gastroenterologist and the Founding Medical Director at Oshi Health, where I’ve had the privilege of helping shape and expand a virtual-first GI care model now serving patients in all 50 states. Working alongside an incredible team, I’ve contributed to building scalable clinical pathways for IBS, IBD, and other gut conditions—anchored in team-based care, empathy, and measurable outcomes.

With 28,000 + followers, I’m among the most followed gastroenterologists on LinkedIn, where I regularly share insights on topics including:

• IBS & the gut-brain connection — emotional triggers, stress, and personalized care
• Digital health innovation — virtual-first models, AI in GI, and wearable integration
• Colorectal cancer screening — rethinking pathways and improving early detection
• Reducing unnecessary testing — CTs, labs, and low-yield procedures in IBS
• Value-based gastroenterology — lower cost, better outcomes, patient experience
• Health plan integration — improving patient access to covered virtual GI care
• Microbiome & nutrition science — evidence-based takes on fiber, probiotics, and gut myths
• Healthcare system reform — tackling disparities, burnout, and reimbursement models
• Behavioral science in GI — the role of habit loops, psychology, and coaching in digestive health
• Virtual care leadership — insights from helping scale a 50-state GI operation

As a LinkedIn Top Voice, I collaborate across digital health, clinical care, and health plans to drive forward-thinking solutions in gastroenterology—without waste, and with humanity.

Let’s connect if you’re working at the intersection of GI, tech-enabled care, or value-based delivery models.

Michael Bass, M.D.

uLogica, LLC

As your Technology Commercialization Partner (TCP), uLogica is uniquely positioned to provide specialized services that propel the market expansion of Groundbreaking Innovative Life Science Technologies (pharmaceutical, biotechnology, precision medicine, and medical devices), Clean Energy & Infrastructure Development throughout North America, Latin America, the Middle East, and Europe.

uLógica creates shared value through Partnerships that develop new products/services, then the Partnership benefits from our Technology Commercialization capabilities. 
This success-based experience guides those Partnerships through corporate strategies, impact investing and product marketing decisions, thus positive results in solving the most difficult issues.

Our ELIN (Extensive Local International Network) of companies and individuals is a creation of mutually satisfying business relationships with the objectives of our Partnership in mind. The ELIN allows flexibility, resourcefulness, and efficiency to accomplish the commercialization goals for our projects.

uLógica, your logical choice for Life Sciences!

Partner, Business and Technology Development

Partner Technology and Business Development

OWL Metabolomics

Collaborate at senior leadership level with laboratories, pharmaceutical companies and relevant clinical research centers to broaden knowledge and application of novel metabolomic assays developed within the OWL laboratories.
 
OWL is a biotechnology company positioned in the field of human metabolomic profiling with pioneering diagnostic products and unique R&D services for clinical research and human application.

Metabolomics specifically describes metabolic alterations in biological samples and this process provides a real-time, repeatable assessment of incremental changes in patient health status. 
Information derived from complex biochemical processes has proven highly valuable in monitoring drug mechanisms, patient response to new drug therapy, toxicology, continued biomarker discovery and optimization of current biotechnological processes. 

The "OWL Liver Test" and "OWL Liver Care" assays are the world's first in-vitro tests for diagnosing NASH and hepatic steatosis (NAFLD), respectively, using micro-blood samples ( <0.5 ml) versus today's diagnostic gold-standard which mandates an invasive liver biopsy.

The company also develops highly-specific diagnostic research markers for other prevalent human diseases.

For more information, please visit http://www.owlmetabolomics.com

Manager, Business and Technology Development - concurrent activity

NUUBO

Led and advised a team of European professionals regarding technology development and product expansion into the North American ambulatory cardiac monitoring market.  Nuubo is currently producing novel patient-wearable monitoring systems for delivering state-of-the-art arrhythmia monitoring. 

For more information, please visit  http://www.nuubo.com/index.php?q=en

Director, Business and Technology Development - concurrent activity

Health In Code, S.L.

Organize, coordinate, and direct ongoing industry collaboration, market research, and strategic business development for US-launch of Health in Code (target launch mid 2015).  

Health in Code (HIC) is a technology-based molecular genetics diagnostics organization established to identify inherited (familial) cardiac health issues in affected patients and their first-line (blood) relatives through NGS (Next Generation Sequencing) / massively parallel gene sequencing, its clinical interpretation and ultimate diagnosis. 

Inherited cardiovascular diseases are HIC’s current core focus of research activity, providing cardiologists, electrophysiologists and genetic specialists unique state-of-the-art diagnostics to leverage personalized medicine in clinical practice. 
 
For more information, please visit     http://www.healthincode.com/index.php?lang=en

Market Development Consultant -NGS Next Generation Sequencing  - concurrent activity

NayaMed-Medtronic

Lead Account Manager for IPGs and ICDs (cardiac implantable electronic devices) for NayaMed International, Sarl, Lausanne, a new Medtronic Corporation subsidiary.  NayaMed's unique technology offers a valuable new online- and web-supported care system for the initial operating room cardiac device implantation. 
Subsequent patient device interrogations and/or device programming changes are enabled via live connection to NayaMed's  certified 24/7/365 remote technical team (see videos below). 
 
Additionally, a unique real-time ERP-scanning system automatically replenishes all medical materials used in the course of the active cardiac device implantation. 

Responsible for German market technical and business development operations. 

Visit links for further recent examples of clinic technical / promotional activity: 

https://www.youtube.com/watch?v=VPDTUvbRHM0  
https://www.youtube.com/watch?v=Fa4DCkMiwTo  
https://www.youtube.com/watch?v=iLW7C_5hQiE 
https://www.youtube.com/watch?v=C_kr-tqy5XY

Lead Germany New Account Manager

BIOTRONIK

Responsible for all marketing activities surrounding worldwide implementation and expansion of the implanted cardiac device patient remote monitoring system.  Created and managed global launch of new clinician web interface + device interpretation and organized numerous in-clinic trainings, workshops, lectures on a global basis. 

Visit link for full description of previous activities (with video) 

http://www.biotronik.com/wps/wcm/connect/en_de_web/biotronik/sub_top/healthcareprofessionals/Products+and+Therapies/home_monitoring/#jump

Global Marketing Manager Remote Cardiac Monitoring

Bristol-Myers Squibb

Specialty Sales and Training Manager for cardiovascular / metabolic products which included onboarding of new employees for detailed technical promotional activities within purchasing groups, hospitals and  office-based clinical settings in Southwest-USA.

Hospital Specialist and Sales Training Manager

Roche

Product Manager and Senior Marketing representative for cardiac immunoassay diagnostic systems and thrombolytic therapy.

Product Manager, Immunoassay Diagnostics

Pfizer

Marketing and new product launch responsibilities for Norvasc (amlodipine) and di-nitrate cardiovasculars.

Senior Product Manager

"Persistence is the rocky road to success"  -- an approach driving most of life's great endeavors.  

Enthusiastic team leader with skill for strategic business analysis and subsequent tactical launches of impactful commercialization activities for the advancement of cutting-edge medical products and related medical concepts globally. 

Successful networker and negotiator with global experience launching and promoting novel healthcare-delivery solutions, while producing documented results in complex, multi-cultural business environments that demand interpersonal finesse, teamwork, autonomy and absolute work integrity. 

A charismatic and goal-focused leader with significant healthcare experience and deep understanding of international cultures.  Established successful track record in marketing and specialty sales management within molecular diagnostics, implantable medical devices (Class III), and cardio-metabolic pharmaceuticals in the United States and Europe. 

Particular competencies: 

• Biotech / Life Science / Genetics  •  Product  Launch, Healthcare Market Development
• Synergies in Matrix Organizations • New Business Development and Strategic Alliances
• Market Competitiveness & Benchmarking •	Product Lifecycle Development
• Strategic Pricing and Distribution • Product Roadmap and Channel Strategies 
• Medical Device Reimbursement • Cardiologists & Electrophysiology  • Commercialization
• Medical Liaisons & KOL-relations  •  Cardiology & Metabolics  •  Patient Remote Monitoring

taplio

The Battle

Michael Bass, M.D.

Tim Montgomery

Followers

Posts

Engagements

Likes

Ready to grow your LinkedIn presence?